Archive for the ‘Penny Stocks’ Category

« Older Entries
Newer Entries »

Arena Pharmaceuticals, Inc. (ARNA) – Buzz Stock of the Day

Thursday, July 1st, 2010

Shares of drug maker Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) surged 20 percent from Wednesday’s close, in morning trading on Thursday after it was announced that Japanese drug maker, Eisai, Inc. will market Arena’s obesity treatment lorcaserin in the U.S.

“Execution of this commercial agreement is a major milestone in our plans for lorcaserin,” said Jack Lief, Arena’s President and Chief Executive Officer. “We believe in Eisai’s human health care mission to satisfy unmet medical needs and increase benefits to patients and their families.”

Here are a few highlights from the deal:

  • $50 million initial upfront (kind of small when considering the potential of the drug)
  • $90 million upon FDA Approval (PDUFA October 22nd) bringing upfront for US marketing rights to $140 million
  • $1.16B in one-time purchase price adjustments after certain sales goals.
  • 31.5-36.5% of annual Lorcaserin sales

    • [–quote–]
    The U.S. Food and Drug Administration is already reviewing lorcaserin, and an decision is expected on Oct. 22. The main concern with lorcaserin is that patients treated with the drug in two pivotal phase III studies didn’t lose much weight — a little more than 3% on a placebo adjusted basis. The biggest plus in lorcaserin’s corner is the drug’s safety and tolerability, which appear better than competing drugs.

    “With Eisai, we have the right company to market lorcaserin in the United States, the right type of agreement to optimize lorcaserin’s medical and commercial potential and the shared recognition that it is the right time to enter into this agreement to prepare for launch following FDA approval,” Lief said.

    Tags: , , , , ,
    Posted in Health Care Stocks, Penny Stocks | 1 Comment »

    Penny Buzz Stocks to Watch on 6/29: VIDA, ECRY, GOIG

    Tuesday, June 29th, 2010

    For all you penny stock traders, here are a few penny Buzz Stocks we’re watching today:

    Vidaroo Corp. (OTCBB: VIDA): Vidaroo announced that the company was selected by country music artist Keith Urban to provide creative visual elements and video production for the Summer Lovin’ 2010 Tour. Several newsletters also promoting the company. Vidaroo Corporation is a video technology company that provides the best-in-breed Online Video Platform, video production and advertising on its Online Video Network that reaches over 10 million visitors monthly. Shares up 88 percent from Monday’s close.

    eCrypt Technologies, Inc. (OTCBB: ECRY): Shares up 5 percent after the company announced positive feedback from their participation in the F5 Expo held in Vancouver, BC on April 7, 2010. According to data from the F5 Expo, eCrypt Technologies, Inc. received the greatest amount of public interest at the conference. These finding are based on the number of voluntary video testimonials the Company received at the F5 media centre. eCrypt Technologies, Inc. is an information security firm with a focus on the wireless industry. The company’s flagship product “eCrypt” is a first-of-its-kind encryption software for wireless email on BlackBerry® smartphones, and is available under a perpetual license or on a pay-per-use basis.

    GoIP Global, Inc. (Pink Sheets: GOIG): Shares up 5 percent today after the company announced that it would receive $5 million in funding from Chinese industrialist, Yidong Fu in return for restricted common shares of the company’s stock. The funds are expected to be used to further GoIP’s GO800’s marketing efforts in USA/Canada, establish a GO800 subsidiary in China, and to launch GO800 in China in 2011.

    Remember to sign up for our FREE alerts!

    Tags: , , , , , ,
    Posted in Industrial Stocks, Penny Stocks, Technology Stocks | No Comments »

    Buzz Stocks Week in Review — EFJI, ETRM, LTBR, MIPI

    Friday, June 25th, 2010

    AVERAGE WEEKLY GAIN:  70.75%

    Here’s a quick recap of how this week’s Buzz Stocks fared:

    Monday: Shares of EF Johnson Technologies, Inc. (Nasdaq: EFJI) rose 40 percent from last Friday’s close in morning trading on Monday after the company increased its sale price 42 percent. The company will now be acquired by Francisco Partners, an affiliate of a private equity firm for $1.50 per share in cash, up from $1.05 per share.
    Up as much as 40% since our post.

    Tuesday: EnteroMedics, Inc. (Nasdaq: ETRM) was our biggest gainer of the week. Shares opened at $0.31 on Tuesday, and climbed nearly 53 percent to a close of $0.61 after the company announced positive data from its obesity treatment device. The following day, shares soared to $0.81, before settling back down to a closing price of $0.63.
    Up as much as 125% since our post.

    Wednesday: Lightbridge Corp. (Nasdaq: LTBR) shares were up 50 percent on Wendesday after the nuclear fuel technology developer announced “a major technological breakthrough,” based on a proprietary all-metal fuel assembly design could reduce both initial capital costs per megawatt and annual operating costs per kilowatt-hour of nuclear power. According to a recent news release, this breakthrough makes nuclear power more competitive with other forms of electricity generation while contributing to a significant reduction of CO2 emissions.
    Up as much as 69% since our post.

    Thursday: Molecular Insight Pharmaceuticals, Inc. (Nasdaq: MIPI) was first featured as a Buzz Stock of the Day on June 18th after shares rose 30 percent from the previous day’s close, about a week after the company presented nonclinical data demonstrating the utility of the Company’s novel radiopharmaceutical compounds for the molecular imaging of prostate and other tumors. Less than a week later, shares surged 65 percent from Wednesday’s closing price of $1.60, trading at at a high of $2.64 on Thursday after Molecular Insight Pharmaceuticals, Inc. announced positive data from a completed Phase 2a clinical study of Azedra™, the Company’s lead oncology therapeutic for a common childhood cancer.
    Up as much as 49% since our post.

    Don’t forget to sign up to receive our FREE Buzz Stocks alerts, and download our E-book, Trade 4 Success!

    Tags: , , , , , , , ,
    Posted in Energy Stocks, Health Care Stocks, Penny Stocks, Technology Stocks | No Comments »

    UPDATE — Molecular Insight Pharmaceuticals, Inc. (MIPI) – Buzz Stock of the Day

    Thursday, June 24th, 2010

    We first featured Molecular Insight Pharmaceuticals, Inc. (Nasdaq: MIPI) on June 18th, after the company announced nonclinical data demonstrating the utility of the Company’s novel radiopharmaceutical compounds for the molecular imaging of prostate and other tumors at the Society of Nuclear Medicine (SNM) annual meeting in Salt Lake City.

    Less than a week later, Molecular Insight Pharmaceuticals announced positive data from a completed Phase 2a clinical study of Azedra™, the Company’s lead oncology therapeutic for a common childhood cancer. Shares were up more than 65 percent from Wednesday’s closing price, in morning trading on Thursday on almost 10-times the company’s average three-month trading volume.

    [–quote–]

    The company said data from the Azedra study showed that doses of 12 millicurie/kg to 18 millicurie/kg of the drug were tolerated without toxicity and the drug was active in tumors. The main goal of the study was to determine the maximum tolerated dose of Azedra.

    “We showed that Ultratrace iobenguane I-131 with AHSC support is feasible at 18 mCi/kg without significant toxicity and with promising partial and complete responses that support proceeding to a pivotal Phase 2 study at18 mCi/kg,” said lead investigator Katherine K. Matthay, M.D., the Mildred V. Strouss Professor of Translational Cancer Research and Chief, Pediatric Hematology-Oncology in Department of Pediatrics at the University of California, San Francisco.

    Azedra is currently in advanced clinical trials for the treatment of malignant pheochromocytoma, a rare, hard-to-access neuroendocrine tumor that develops in the core of an adrenal gland.

    Tags: , , , ,
    Posted in Health Care Stocks, Penny Stocks | 1 Comment »

    EnteroMedics, Inc. (ETRM) – Buzz Stock of the Day

    Tuesday, June 22nd, 2010

    Shares of medical device maker, EnteroMedics, Inc. (Nasdaq: ETRM) soared 75 percent from Monday’s closing price, in morning trading on Tuesday after the company announced positive data from an ongoing feasibility study of the Maestro System in obese patients with Type-2 diabetes mellitus. The study was designed to evaluate the safety and efficacy of the Company’s next-generation Maestro RC System, which treats obesity.

    James Toouli, M.D., professor of surgery at Flinders University in Adelaide, Australia, and one of the study’s investigators said the results from the study showed “significant, sustained improvements in glycemic control and blood pressure as well as clinically meaningful weight loss, without a compromise in patient safety.”

    [–quote–]

    Data from the Empower study, in which over 400 patients have used the Maestro System device, showed significant weight loss and control of obesity related co-morbidities.

    EnteroMedics’ device, which is implanted laparoscopically, blocks the vagus nerves periodically using high-frequency, low-energy electrical impulses.

    “Across a number of studies, we have observed clinically significant weight loss and control of obesity related co-morbidities as well as a safety profile that distinguishes this system from all other bariatric surgical procedures. We are particularly encouraged by the strong, positive feedback from the metabolic and bariatric surgery community,” said EnteroMedics’ President and CEO Mark B. Knudson, Ph.D in a statement.

    Tags: , , , ,
    Posted in Health Care Stocks, Penny Stocks, Technology Stocks | 1 Comment »

    « Older Entries
    Newer Entries »